Utilizing a newly created artificial intelligence (AI)-based assay development system, Seegene Inc, Seoul, South Korea, has developed two multiplexed molecular diagnostics for meningitis and sexually transmitted infections. The assays are based on Allplex real-time polymerase chain reaction (PCR) reagents designed to detect eight different DNA targets simultaneously. The Seegene digitized development system automates real-time PCR assay development, driving down the cost of molecular diagnostic tests and enabling nonprofessionals to develop multiplexed assays. The company’s pipeline of products includes assays that diagnose not only infectious diseases but also drug-resistant pathogens, genetic disorders, and various cancers, including breast, colon, and lung cancers. For more information, visit Seegene.